Page 5 - HPP ANTIMICROBIAL GUIDELINE 2018
P. 5

FOREWORD


                   I would like to take this opportunity to congratulate all contributors and reviewers
            of the first edition Hospital Pulau Pinang Antimicrobial Guideline (HPP AMG) 2018.
            The  writing  group  has  taken  great  effort  in  compiling  and  drawing  up  the  most
            appropriate antimicrobial therapy for each systemic infection taking into consideration
            of our own hospital antibiogram and clinicians’ preference guided by evidence-based
            medicine.


                   In the report of the National Surveillance on Antimicrobial Utilization 2017, HPP
            was one of the 5 hospitals with the highest prescriptions of cephalosporins, especially
                  th
            the 4  generation cephalosporin and carbapenems. The utilization of these antibiotics
            continues to rise between the months of January to June 2018 as highlighted in the recent
            Infection Control Meeting 3/2018. The utilization of IV vancomycin increased by 40
            %, IV imipenem/cilastatin increased 21%, IV meropenem increased 13% and IV colistin
            increased 25%. The rise in the rates of Multi Drug Resistant (MDR ) organisms eg.

            Extended  Spectrum  Beta  Lactamases  (ESBL)  Klebsiella  pneumoniae,  ESBL  E.coli,
            Carbapenem  Resistant  Enterobacteriaceae  (CRE)  and  Carbapenem  Resistant
            Acinetobacter baumannii in this hospital is worrying to all clinicians.

                   This guideline aims to provide effective and appropriate treatment options for
            common  infections  presenting  to  HPP.  It  encourages  the  use  of  narrow  spectrum
            antibiotics in mild to moderate infections but does not restrict broad spectrum antibiotics

            in  more  severe  infections.  Antimicrobial  audit  will  be  carried  out  yearly  in  Point
            Prevalence Study 2.0 from Ministry of Health in the month of October. It is imperative
            to document the indication of initiating antimicrobial in the patient’s note clearly and a
            review of the need to either de-escalate, stop or continue therapy must be done 48-72
            hours after initiation. This guideline will be used in the audit for appropriateness of

            therapy.

                   I sincerely hope that all the clinicians in HPP will  give their support for this
            guideline in the management of infections in order to reduce inappropriate antimicrobial
            prescription.

            Thank you.




            Dato’ Dr. Norsidah BT. Ismail
            D.S.P.N, P.K.T
            MMC Full Reg. No: 27959
            Pengarah Hospital
            Hospital Pulau Pinang


            HPP AMG
   1   2   3   4   5   6   7   8   9   10